Vicarious Surgical (RBOT) Competitors

Vicarious Surgical (NYSE:RBOT) and Inogen (NASDAQ:INGN) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, valuation, community ranking, institutional ownership, media sentiment, analyst recommendations, dividends, earnings and profitability.

Do analysts prefer RBOT or INGN?

Vicarious Surgical presently has a consensus price target of $9.25, suggesting a potential upside of 34.16%. Inogen has a consensus price target of $9.50, suggesting a potential upside of 40.74%. Given Inogen's stronger consensus rating and higher probable upside, analysts plainly believe Inogen is more favorable than Vicarious Surgical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Vicarious Surgical	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Inogen	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.50

Does the MarketBeat Community believe in RBOT or INGN?

Inogen received 382 more outperform votes than Vicarious Surgical when rated by MarketBeat users. Likewise, 68.78% of users gave Inogen an outperform vote while only 32.00% of users gave Vicarious Surgical an outperform vote.

Company	Underperform	Outperform
Vicarious Surgical	Outperform Votes 8 32.00%	Underperform Votes 17 68.00%
Inogen	Outperform Votes 390 68.78%	Underperform Votes 177 31.22%

Which has preferable earnings & valuation, RBOT or INGN?

Vicarious Surgical has higher earnings, but lower revenue than Inogen. Inogen is trading at a lower price-to-earnings ratio than Vicarious Surgical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Vicarious Surgical	N/A	N/A	-$71.07M	-$10.45	-0.66
Inogen	$339.96M	0.53	-$102.45M	-$1.15	-5.87

Does the media prefer RBOT or INGN?

In the previous week, Inogen had 3 more articles in the media than Vicarious Surgical. MarketBeat recorded 6 mentions for Inogen and 3 mentions for Vicarious Surgical. Inogen's average media sentiment score of 0.96 beat Vicarious Surgical's score of -0.67 indicating that Inogen is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Vicarious Surgical	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Negative
Inogen	3 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Do insiders and institutionals have more ownership in RBOT or INGN?

47.3% of Vicarious Surgical shares are held by institutional investors. Comparatively, 89.9% of Inogen shares are held by institutional investors. 12.0% of Vicarious Surgical shares are held by insiders. Comparatively, 1.5% of Inogen shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Which has more volatility & risk, RBOT or INGN?

Vicarious Surgical has a beta of 1.46, suggesting that its stock price is 46% more volatile than the S&P 500. Comparatively, Inogen has a beta of 1.63, suggesting that its stock price is 63% more volatile than the S&P 500.

Is RBOT or INGN more profitable?

Vicarious Surgical has a net margin of 0.00% compared to Inogen's net margin of -15.89%. Inogen's return on equity of -27.38% beat Vicarious Surgical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Vicarious Surgical	N/A	-81.46%	-63.62%
Inogen	-15.89%	-27.38%	-16.77%

Summary

Inogen beats Vicarious Surgical on 13 of the 17 factors compared between the two stocks.